查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球复合药房市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342731

全球复合药房市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Compounding Pharmacies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 232 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2030 年，全球复合药房市场的市场规模将从 2022 年的 144.4 亿美元达到近 282.3 亿美元，2023-2030 年研究期间复合年增长率为 8.74%。

配製药房是获得定製药物的安全可靠的方式。复合药房是特定类型的药房。復配药房是根据市售药物无法满足的特定患者的需要，为特定患者配製医生处方的药物。复合药房可以根据患者的喜好和限制创建定製剂型。复合药房只会发行通过医生处方获得的药物。调配药房会接受额外的质量评估，以向消费者保证产品已按照调配标准进行调配。

市场动态

癌症等慢性疾病变得越来越普遍，随着复合药房资金的增加，将在预测期内提振市场。此外，药品短缺也是该地区復方药店增长的一个重要原因。此外，人们对复合药物益处的认识不断增强，将导致此类个性化药物的使用量增加，并导致市场增长。主要市场参与者在研发方面的投资激增，以创新和定製配方以有效治疗各种疾病，预计将推动复方药房市场的增长。然而，对製造复杂配方的限制增加可能会阻碍市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球复合药房市场的每个细分市场进行了包容性评估。复合製药行业的增长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲复合药房市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。复合药房市场的主要参与者包括 Fagron、B. Braun、Nephron Pharmaceuticals Corporation、Fresenius Kabi、Athenex Pharma Solutions (Athenex Inc.)、Dougherty's Pharmacy, Inc.、Clinigen Group PLC、Pencol Complexing Pharmacy、Lorraine's Pharmacy、McGuff Company Inc .（McGuff 复合药房服务）、Institutional Pharmacy Solutions、Rx3 复合药房、Wedgewood Village Pharmacy, Inc. 和Triangle 复合药房。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：复合药剂 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按治疗领域分類的市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：按应用分类
    • 按复利类型进行的市场吸引力分析
    • 按不育性进行市场吸引力分析
    • 按分销渠道分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球复方药市场分析：按治疗领域

  • 按治疗领域概述
  • 历史和预测数据
  • 按治疗领域分析
  • 皮肤科
  • 疼痛管理
  • 特殊药物
  • 营养补充剂
  • 激素替代品
  • 其他的

第 7 章：全球复合製药市场分析：按产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 口服（固体製剂、液体製剂）
  • 局部用药（霜剂、凝胶剂、软膏剂、糊剂、其他
  • 直肠（灌肠剂、栓剂、其他）
  • 肠外注射（LVP、SVP）
  • 眼科
  • 鼻腔
  • 奥迪克

第 8 章：全球复合药房市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 儿科
  • 老年科
  • 成人
  • 兽医

第 9 章：全球复方药房市场分析：按复方类型

  • 按复合类型概述
  • 历史和预测数据
  • 按复合类型分析
  • 药物剂量变更 (PDA)
  • 药物成分变更 (PIA)
  • 目前不可用的药品製造 (CUPM)
  • 其他的

第 10 章：全球复合药房市场分析：按无菌度

  • 无菌概述
  • 历史和预测数据
  • 无菌分析
  • 非无菌
  • 无菌

第 11 章：全球复合药房市场分析：按分销渠道

  • 按分销渠道分類的概览
  • 历史和预测数据
  • 按分销渠道分析
  • 复方药剂
  • 医院药房
  • 其他的

第 12 章：全球复合药房市场销售分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 13 章：复方製药公司的竞争格局

  • 复合药房市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 14 章：公司简介

  • 顶级公司股票分析
  • 市场集中度
  • Fagron
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • B. Braun
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nephron Pharmaceuticals Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Fresenius Kabi
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Athenex Pharma Solutions (Athenex Inc.)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dougherty's Pharmacy Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Clinigen Group PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pencol Compounding Pharmacy
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lorraine's Pharmacy
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • McGuff Company Inc. (McGuff Compounding Pharmacy Services)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Institutional Pharmacy Solutions
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Rx3 Compounding Pharmacy
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Wedgewood Village Pharmacy Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Triangle Compounding Pharmacies
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219448

The global demand for Compounding Pharmacies Market is presumed to reach the market size of nearly USD 28.23 BN by 2030 from USD 14.44 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

Compounding pharmacies are a safe and reliable way to receive customized medications. Compounding pharmacies are specific types of pharmacies. Compounding pharmacies are to make drugs prescribed by doctors for specific patients with needs that commercially available drugs cannot meet. Compounding pharmacies can create customized dosage forms based on patient preferences and restrictions. Compounding pharmacies will only issue those medications obtained via a doctor's prescription. Compounding pharmacies undergo an extra quality assessment to assure consumers that the product has been compounded to compounding standards.

MARKET DYNAMICS

The chronic diseases such as cancer are becoming more common along with increasing funding for compounding pharmacies will boost the market over the forecast period. Also, the shortage of drugs is a strong reason for the growth of compounding pharmacies across the region. Moreover, the growing awareness about the benefits of compounded medications will lead to higher use of such personalized medications and result in market growth. The surging investments by the key market players in research and development to innovate and customize the formulations to effectively treat various diseases are expected to boost the growth of the compounding pharmacies market. However, increased restrictions on manufacturing complex formulations may hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounding pharmacies. The growth and trends of compounding pharmacies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the compounding pharmacies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutic Area

  • Dermatology
  • Pain Management
  • Specialty Drugs
  • Nutritional Supplements
  • Hormone Replacement
  • Others

By Product

  • Oral (Solid Preparations, Liquid Preparations)
  • Topical (Creams, Gels, Ointments, Pastes, Others
  • Rectal (Enema, Suppositories, Others)
  • Parenteral (LVP, SVP)
  • Ophthalmic
  • Nasal
  • Otic

By Application

  • Pediatric
  • Geriatric
  • Adult
  • Veterinary

By Compounding Type

  • Pharmaceutical Dosage Alteration (PDA)
  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

By Sterility

  • Non-Sterile
  • Sterile

By Distribution Channel

  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Compounding Pharmacies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounding pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty's Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc. and Triangle Compounding Pharmacies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . COMPOUNDING PHARMACIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Compounding Type
    • 3.7.5 Market Attractiveness Analysis By Sterility
    • 3.7.6 Market Attractiveness Analysis By Distribution Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1 Overview by Therapeutic Area
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapeutic Area
  • 6.4 Dermatology Historic and Forecast Sales by Regions
  • 6.5 Pain Management Historic and Forecast Sales by Regions
  • 6.6 Specialty Drugs Historic and Forecast Sales by Regions
  • 6.7 Nutritional Supplements Historic and Forecast Sales by Regions
  • 6.8 Hormone Replacement Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Oral (Solid Preparations, Liquid Preparations) Historic and Forecast Sales by Regions
  • 7.5 Topical (Creams, Gels, Ointments, Pastes, Others Historic and Forecast Sales by Regions
  • 7.6 Rectal (Enema, Suppositories, Others) Historic and Forecast Sales by Regions
  • 7.7 Parenteral (LVP, SVP) Historic and Forecast Sales by Regions
  • 7.8 Ophthalmic Historic and Forecast Sales by Regions
  • 7.9 Nasal Historic and Forecast Sales by Regions
  • 7.10. Otic Historic and Forecast Sales by Regions

8 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Pediatric Historic and Forecast Sales by Regions
  • 8.5 Geriatric Historic and Forecast Sales by Regions
  • 8.6 Adult Historic and Forecast Sales by Regions
  • 8.7 Veterinary Historic and Forecast Sales by Regions

9 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY COMPOUNDING TYPE

  • 9.1 Overview by Compounding Type
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Compounding Type
  • 9.4 Pharmaceutical Dosage Alteration (PDA) Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical Ingredient Alteration (PIA) Historic and Forecast Sales by Regions
  • 9.6 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY STERILITY

  • 10.1 Overview by Sterility
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Sterility
  • 10.4 Non-sterile Historic and Forecast Sales by Regions
  • 10.5 Sterile Historic and Forecast Sales by Regions

11 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 11.1 Overview by Distribution Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Distribution Channel
  • 11.4 Compounding Pharmacy Historic and Forecast Sales by Regions
  • 11.5 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 11.6 Others Historic and Forecast Sales by Regions

12 . GLOBAL COMPOUNDING PHARMACIES MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE COMPOUNDING PHARMACIES COMPANIES

  • 13.1. Compounding Pharmacies Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF COMPOUNDING PHARMACIES INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Fagron
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. B. Braun
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Nephron Pharmaceuticals Corporation
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Fresenius Kabi
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Athenex Pharma Solutions (Athenex Inc.)
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Dougherty's Pharmacy Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Clinigen Group PLC
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Pencol Compounding Pharmacy
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. Lorraine's Pharmacy
    • 14.11.1. Company Overview
    • 14.11.2. Company Revenue
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. McGuff Company Inc. (McGuff Compounding Pharmacy Services)
    • 14.12.1. Company Overview
    • 14.12.2. Company Revenue
    • 14.12.3. Products
    • 14.12.4. Recent Developments
  • 14.13. Institutional Pharmacy Solutions
    • 14.13.1. Company Overview
    • 14.13.2. Company Revenue
    • 14.13.3. Products
    • 14.13.4. Recent Developments
  • 14.14. Rx3 Compounding Pharmacy
    • 14.14.1. Company Overview
    • 14.14.2. Company Revenue
    • 14.14.3. Products
    • 14.14.4. Recent Developments
  • 14.15. Wedgewood Village Pharmacy Inc.
    • 14.15.1. Company Overview
    • 14.15.2. Company Revenue
    • 14.15.3. Products
    • 14.15.4. Recent Developments
  • 14.16. Triangle Compounding Pharmacies
    • 14.16.1. Company Overview
    • 14.16.2. Company Revenue
    • 14.16.3. Products
    • 14.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Compounding Pharmacies Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Compounding Pharmacies Report
  • Market Research Process
  • Market Research Methodology
  • Global Compounding Pharmacies Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Compounding Type
  • Market Attractiveness Analysis by Sterility
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Global Market Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.